Franklin Resources’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-41,994
| Closed | -$611K | – | 2432 |
|
|
2021
Q4 | $611K | Buy |
41,994
+5,394
| +15% | +$78.5K | ﹤0.01% | 1835 |
|
|
2021
Q3 | $659K | Buy |
+36,600
| New | +$659K | ﹤0.01% | 1780 |
|
|
2019
Q3 | – | Sell |
-3,845,423
| Closed | -$8.42M | – | 1507 |
|
|
2019
Q2 | $8.42M | Sell |
3,845,423
-159,391
| -4% | -$349K | ﹤0.01% | 932 |
|
|
2019
Q1 | $24M | Buy |
4,004,814
+18,392
| +0.5% | +$110K | 0.01% | 701 |
|
|
2018
Q4 | $29.5M | Buy |
3,986,422
+1,088,112
| +38% | +$8.04M | 0.02% | 610 |
|
|
2018
Q3 | $42.1M | Sell |
2,898,310
-72,155
| -2% | -$1.05M | 0.02% | 585 |
|
|
2018
Q2 | $59.3M | Buy |
2,970,465
+395,074
| +15% | +$7.89M | 0.03% | 491 |
|
|
2018
Q1 | $45.1M | Sell |
2,575,391
-21,423
| -0.8% | -$375K | 0.02% | 565 |
|
|
2017
Q4 | $64M | Buy |
2,596,814
+565,945
| +28% | +$14M | 0.03% | 476 |
|
|
2017
Q3 | $52.4M | Buy |
2,030,869
+75,488
| +4% | +$1.95M | 0.03% | 515 |
|
|
2017
Q2 | $53M | Buy |
1,955,381
+697,104
| +55% | +$18.9M | 0.03% | 516 |
|
|
2017
Q1 | $37.5M | Sell |
1,258,277
-269,272
| -18% | -$8.03M | 0.02% | 611 |
|
|
2016
Q4 | $41.5M | Sell |
1,527,549
-39,964
| -3% | -$1.08M | 0.02% | 573 |
|
|
2016
Q3 | $40.1M | Sell |
1,567,513
-7,371
| -0.5% | -$189K | 0.02% | 593 |
|
|
2016
Q2 | $29.1M | Sell |
1,574,884
-64,570
| -4% | -$1.19M | 0.02% | 692 |
|
|
2016
Q1 | $31.1M | Sell |
1,639,454
-15,440
| -0.9% | -$293K | 0.02% | 682 |
|
|
2015
Q4 | $44.6M | Buy |
+1,654,894
| New | +$44.6M | 0.02% | 582 |
|